Insider Transaction Report for Simon Barry J. at ImmunityBio, Inc.

Simon Barry J., a director at ImmunityBio, Inc. (IBRX), reported a sale of 25,000 shares of Common Stock on June 24, 2026. The sale was executed as part of a Rule 10b5-1 trading plan adopted on December 18, 2025. The shares were sold at a weighted average price of $7.8763, within a price range of $7.875 to $7.885. Following this transaction, Simon Barry J. directly owns 2,802,788 shares of Common Stock. The filing includes an undertaking to provide full information regarding the number of shares sold at each separate price upon request by the Commission staff, the Issuer, or a security holder.